The Journal of Bone and Joint Surgery 82:161-73 (2000)
© 2000 The Journal of Bone and Joint Surgery, Inc.
Ciprofloxacin Inhibition of Experimental Fracture-Healing*
P. M. HUDDLESTON, M.D. ,
J. M. STECKELBERG, M.D.,
A. D. HANSSEN, M.D.,
M. S. ROUSE, B.S.,
M. E. BOLANDER, M.D. and
R. PATEL, M.D., ROCHESTER, MINNESOTA
Investigation performed at Mayo Clinic and Mayo Foundation, Rochester
Background: Fluoroquinolones, such as ciprofloxacin, have an adverse effect on growing cartilage and endochondral ossification in children. This study was carried out to determine whether ciprofloxacin also has an adverse effect on the healing of experimental fractures.
Methods: Sixty male 300-gram Wistar rats were divided equally into three groups, which received ciprofloxacin, cefazolin, or no treatment for three weeks, beginning seven days after production of a closed, nondisplaced, bilateral femoral fracture. The serum concentrations of the ciprofloxacin and the cefazolin were 2.4 and 146 micrograms per milliliter, respectively. Radiographic, histological, and biomechanical studies were used to evaluate fracture-healing.
Results: Radiographs revealed significantly more advanced healing of the control fractures compared with the fractures in the ciprofloxacin-treated group (average stage, 2.1 compared with 1.5, p = 0.01). The cefazolin-treated group was not different from the controls with respect to radiographic healing (average stage, 1.8 compared with 2.1, p = 0.18). Torsional strength-testing of fracture callus exposed to ciprofloxacin revealed a 16 percent decrease in strength compared with the controls (284 compared with 338 newton-millimeters, p = 0.04) and a 49 percent decrease in stiffness (twenty compared with thirty-nine newton-millimeters per degree, p = 0.001). The biomechanical strength in the cefazolin-treated group was not different from that of the controls. Fracture calluses in the animals treated with ciprofloxacin showed abnormalities in cartilage morphology and endochondral bone formation and a significant decrease in the number of chondrocytes compared with the controls (0.77 x 104 compared with 1.3 x 104 cells per square millimeter, p = 0.004).
Conclusions: These data suggest that experimental fractures exposed to therapeutic concentrations of ciprofloxacin in serum demonstrate diminished healing during the early stages of fracture repair. The administration of ciprofloxacin during early fracture repair may compromise the clinical course of fracture-healing.
 CiteULike  Connotea  Del.icio.us  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
N. Duewelhenke, O. Krut, and P. Eysel
Influence on Mitochondria and Cytotoxicity of Different Antibiotics Administered in High Concentrations on Primary Human Osteoblasts and Cell Lines
Antimicrob. Agents Chemother.,
January 1, 2007;
51(1):
54 - 63.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Okike and T. Bhattacharyya
Trends in the Management of Open Fractures. A Critical Analysis
J. Bone Joint Surg. Am.,
December 1, 2006;
88(12):
2739 - 2748.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. J. Makinen, M. Veiranto, P. Lankinen, N. Moritz, J. Jalava, P. Tormala, and H. T. Aro
In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler
J. Antimicrob. Chemother.,
December 1, 2005;
56(6):
1063 - 1068.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. G. Stewart Jr., R. M. Kay, and D. L. Skaggs
Open Fractures in Children. Principles of Evaluation and Management
J. Bone Joint Surg. Am.,
December 1, 2005;
87(12):
2784 - 2798.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Patzakis and C. G. Zalavras
Chronic Posttraumatic Osteomyelitis and Infected Nonunion of the Tibia: Current Management Concepts
J. Am. Acad. Ortho. Surg.,
October 1, 2005;
13(6):
417 - 427.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Sarda, A.-C. Cremieux, Y. Lebellec, A. Meulemans, R. Lebtahi, G. Hayem, R. Genin, N. Delahaye, D. Huten, and D. Le Guludec
Inability of 99mTc-Ciprofloxacin Scintigraphy to Discriminate Between Septic and Sterile Osteoarticular Diseases
J. Nucl. Med.,
June 1, 2003;
44(6):
920 - 926.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. G. Zalavras and M. J. Patzakis
Open Fractures: Evaluation and Management
J. Am. Acad. Ortho. Surg.,
May 1, 2003;
11(3):
212 - 219.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. N. Joseph, A. L. Chen, and P. E. Di Cesare
Use of Antibiotic-Impregnated Cement in Total Joint Arthroplasty
J. Am. Acad. Ortho. Surg.,
January 1, 2003;
11(1):
38 - 47.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Sarda, A. Saleh-Mghir, C. Peker, A. Meulemans, A.-C. Cremieux, and D. Le Guludec
Evaluation of 99mTc-Ciprofloxacin Scintigraphy in a Rabbit Model of Staphylococcus aureus Prosthetic Joint Infection
J. Nucl. Med.,
February 1, 2002;
43(2):
239 - 245.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
